Evidence map›Paper›PMID 17139690›Full record

ArticleChembiochem : a European journal of chemical biology2007

Generation of new landomycins with altered saccharide patterns through over-expression of the glycosyltransferase gene lanGT3 in the biosynthetic gene cluster of landomycin A in Streptomyces cyanogenus S-136.

Lili Zhu, Andriy Luzhetskyy, Martha Luzhetska, Cynthia Mattingly, Val Adams, Andreas Bechthold, Jürgen Rohr

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Natural products version 2.0: connecting genes to molecules.Journal of the American Chemical Society · 2010
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lili ZhuDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 725 Rose Street, Lexington, KY 40536-0082, USA.
Andriy Luzhetskyy
Martha Luzhetska
Cynthia Mattingly
Val Adams
Andreas Bechthold
Jürgen Rohr

Funding

NOVEL AUREOLIC ACID TYPE ANTITUMOR AGENTSR01CA091901 · NCI · UNIVERSITY OF KENTUCKY · PI ROHR, JURGEN T · 2001 to 2017
$3.6M
BIOSYNTHETIC KEY STEPS OF ANGUCYCLINE ANTITUMOR DRUGSR01CA102102 · NCI · UNIVERSITY OF KENTUCKY · PI ROHR, JURGEN T · 2005 to 2009
$1.3M
NCI NIH HHS CA102102NCI NIH HHS CA91901NCI NIH HHS R01 CA091901NCI NIH HHS R01 CA102102
6 · The paper itself

Abstract

Two novel landomycin compounds, landomycins I and J, were generated with a new mutant strain of Streptomyces cyanogenus in which the glycosyltransferase that is encoded by lanGT3 was over-expressed. This mutant also produced the known landomycins A, B, and D. All these compounds consist of the same polyketide-derived aglycon but differ in their sugar moieties, which are chains of different lengths. The major new metabolite, landomycin J, was found to consist of landomycinone with a tetrasaccharide chain attached. Combined with previous results of the production of landomycin E (which contains three sugars) by the LanGT3- mutant strain (obtained by targeted gene deletion of lanGT3), it was verified that LanGT3 is a D-olivosyltransferase responsible for the transfer of the fourth sugar required for landomycin A biosynthesis. The experiments also showed that gene over-expression is a powerful method for unbalancing biosynthetic pathways in order to generate new metabolites. The cytotoxicity of the new landomycins--compared to known ones--was assessed by using three different tumor cell lines, and their structure-activity relationship (SAR) with respect to the length of the deoxysugar side chain was deduced from the results.

Indexed as

Multigene FamilyAminoglycosidesBiosynthetic PathwaysChromatography, High Pressure LiquidCloning, MolecularEscherichia coliGene Expression RegulationGlycosyltransferasesMagnetic Resonance SpectroscopyMutationPolysaccharidesStreptomycesStructure-Activity RelationshipAminoglycosidesGlycosyltransferaseslandomycin Alandomycin EPolysaccharides

Identifiers

PMID17139690
PMCPMC2879348

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.